Maggie is the Operational Lead for Translational Histopathology, overseeing the team providing both histological services and human tissue handling and processing for research groups and clinical trials.
June 16, 2020
Maggie is the Operational Lead for Translational Histopathology, overseeing the team providing both histological services and human tissue handling and processing for research groups and clinical trials.
The Mark Foundation Institute for Integrated Cancer Medicine (MFICM) at the University of Cambridge aims to revolutionise cancer care by affecting patients along their treatment pathway.